Results 261 to 270 of about 1,163,658 (291)

Treatment-Resistant Schizophrenia

Psychiatric Clinics of North America, 2016
Although treatment-resistant schizophrenia (TRS) was described 50 years ago and has a gold standard treatment with clozapine based on well-defined criteria, there is still a matter of great interest and controversy. In terms of the underlying mechanisms of the development of TRS, progress has been made for the elucidation of the neurochemical ...
Helio, Elkis, Peter F, Buckley
openaire   +2 more sources

Targeting Treatment-Resistant Depression

Journal of Pharmacy Practice, 2011
Only 50% of depressed patients achieve remission of symptoms after 2 trials of antidepressants. Therefore one half of patients are considered treatment resistant. Studies have shown that with each failed antidepressant, chances of remission continue to decline. Untreated depressive symptoms lead to impaired social and occupational function, decline of
Monica, Mathys, Brian G, Mitchell
openaire   +2 more sources

Treatment-Resistant Depression

Psychotherapy and Psychosomatics, 1998
Our ability to treat depression has improved with the availability of receptor-specific and chemically diverse groups of antidepressants. Even now, most of the short-term studies indicate that about 20% of depressed patients remain resistant to treatment. Therefore, it is important to properly assess the treatment-resistant depressed (TRD) patients and
openaire   +2 more sources

Treatment Resistant Hypertension

American Journal of Therapeutics, 2008
Treatment resistant hypertension is defined as a blood pressure not achieving a goal blood pressure (
openaire   +2 more sources

Treatment-Resistant Schizophrenia

Psychiatric Clinics of North America, 2007
This article opens with a brief history of pharmacologic treatment of schizophrenia. It then discusses the definition and treatment of treatment-resistant schizophrenia, with particular attention to clinical, biological and neuroimaging correlates, as well as the best treatment options, including the use of clozapine in patients who meet the definition
openaire   +2 more sources

Treatment-resistant inflammatory myopathy

Best Practice & Research Clinical Rheumatology, 2010
When confronted with a dermatomyositis or polymyositis patient not responding to immunosuppressive treatment, physicians must first ask whether the original diagnosis was correct. In this review, we provide a guide to the clinical features and ancillary tests, which might be helpful in the differential diagnosis of myositis.
Herman F, Mann   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy